Recently, KIF14 has been reported to regulate the PI3K/AKT pathway by upregulating the phosphorylation of AKT [33, 34, 36–38] and contribute to chemoresistance in breast cancer [38, 39]. Here, AKT1 is linked to breast carcinoma.